SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Azenta
AZTA 30.21-1.8%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: robert b furman who wrote (1022)4/27/2017 9:02:11 AM
From: robert b furman1 Recommendation

Recommended By
The Ox

  Read Replies (1) of 1138
 
CORRECTION:

Earnings due out tonight the 27th AH.

My week has been off all week - please excuse inaccurate update yesterday.

Here's to a blow out number. TER's orders were up 56 % per last nights report and beat with better guidance.

Semi equipment business is good and getting better:

From Briefing.com: 5:05 pm Teradyne beats by $0.06, beats on revs; guides Q2 EPS and rev above consensus ( TER) : Reports Q1 (Mar) adj. earnings of $0.44 per share, $0.06 better than the Capital IQ Consensus of $0.38; revenues rose 6.0% year/year to $457 mln vs the $440.96 mln Capital IQ Consensus. Orders in the first quarter of 2017 were $595 million of which $476 million were in Semiconductor Test, $46 million in System Test, $45 million in Industrial Automation, and $27 million in Wireless Test.

Co issues upside guidance for Q2, sees adj. EPS of $0.81-0.90 vs. $0.60 Capital IQ Consensus Estimate; sees Q2 revs of $660-700 mln vs. $555.19 mln Capital IQ Consensus Estimate.

"Semiconductor Test year over year quarterly orders were up 56% on broad strength in mobile, automotive, industrial analog, and Flash memory end market demand. Universal Robots' (:UR) year over year quarterly sales were up 117% powered by an expanding range of customers embracing the power of UR's collaborative robots to reduce production costs and improve product quality. "With our large backlog and strong first quarter orders, our Q2 revenue is expected to increase 28% year on year at the mid-point of our Q2 guidance. While we expect the familiar seasonality in the second half, we're on track for another year of revenue and operating profit growth."

Imagine what earnings could be with semi equipment being strong and life sciences surprising to the upside = Hello 30's?

Bob

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext